Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report_135_treasury_shares_espi.pdf Notification for sale of treasury shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 135 / 2026
Date of issue: 2026-05-12
Short name of the issuer
SOPHARMA AD
Subject
Notification for sale of treasury shares
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, May 12, 2026 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on May 11, 2026 the Company sold 194 730 (one hundred ninety-four thousand seven hundred and thirty) treasury shares representing 0.04% of the share capital of the Company, at a total value of EUR 365 107.32 on the Bulgarian Stock Exchange, the average price per share was EUR 1.87.
The total number of treasury shares after this transaction is 9 960 270 representing 1.85% of the share capital of the Company.
Annexes
File Description
Current report_135_treasury_shares_espi.pdf
Current report_135_treasury_shares_espi.pdf		 Notification for sale of treasury shares

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-05-12 Ognian Ivanov Donev Executive Director
20260512_082954_0615496779_Current_report_135_treasury_shares_espi.pdf

Pobierz